Related Experiment Video
Updated: Aug 9, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death
Neil Kuehnle1, Scout Mask Osborne1, Ziyan Liang1
1Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Tarry 6-735, Chicago, IL, 60611, USA.
Abstract:
Kaposi's sarcoma-associated herpesvirus (KSHV) causes primary effusion lymphoma (PEL). PEL cell lines require expression of the cellular FLICE inhibitory protein (cFLIP) for survival, although KSHV encodes a viral homolog of this protein (vFLIP). Cellular and viral FLIP proteins have several functions, including, most importantly, the inhibition of pro-apoptotic caspase 8 and modulation of NF-κB signaling. To investigate the essential role of cFLIP and its potential redundancy with vFLIP in PEL cells, we first performed rescue experiments with human or viral FLIP proteins known to affect FLIP target pathways differently. The long and short isoforms of cFLIP and molluscum contagiosum virus MC159L, which are all strong caspase 8 inhibitors, efficiently rescued the loss of endogenous cFLIP activity in PEL cells. KSHV vFLIP was unable to fully rescue the loss of endogenous cFLIP and is therefore functionally distinct. Next, we employed genome-wide CRISPR/Cas9 synthetic rescue screens to identify loss of function perturbations that can compensate for cFLIP knockout. Results from these screens and our validation experiments implicate the canonical cFLIP target caspase 8 and TRAIL receptor 1 (TRAIL-R1 or TNFRSF10A) in promoting constitutive death signaling in PEL cells. However, this process was independent of TRAIL receptor 2 or TRAIL, the latter of which is not detectable in PEL cell cultures. The requirement for cFLIP is also overcome by inactivation of the ER/Golgi resident chondroitin sulfate proteoglycan synthesis and UFMylation pathways, Jagunal homolog 1 (JAGN1) or CXCR4. UFMylation and JAGN1, but not chondroitin sulfate proteoglycan synthesis or CXCR4, contribute to TRAIL-R1 expression. In sum, our work shows that cFLIP is required in PEL cells to inhibit ligand-independent TRAIL-R1 cell death signaling downstream of a complex set of ER/Golgi-associated processes that have not previously been implicated in cFLIP or TRAIL-R1 function.
Insights
Cellular FLICE inhibitory protein (cFLIP) is essential for primary effusion lymphoma (PEL) cell survival by inhibiting cell death pathways. KSHV vFLIP cannot fully replace cFLIP, revealing distinct functions and new therapeutic targets.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Kaposi's sarcoma-associated herpesvirus (KSHV) drives primary effusion lymphoma (PEL) pathogenesis.
- PEL cells critically depend on cellular FLICE inhibitory protein (cFLIP) for survival.
- KSHV encodes a viral FLIP (vFLIP) homolog, raising questions about functional redundancy.
Purpose of the Study:
- To investigate the essential role of cFLIP in PEL cells.
- To determine if KSHV vFLIP can functionally substitute for cFLIP.
- To identify pathways that can compensate for cFLIP loss in PEL cells.
Main Methods:
- Rescue experiments using different FLIP isoforms and viral homologs.
- Genome-wide CRISPR/Cas9 synthetic rescue screens.
- Validation experiments targeting identified pathways and proteins.
Main Results:
- Human cFLIP isoforms and molluscum contagiosum virus MC159L rescued cFLIP loss, but KSHV vFLIP did not fully rescue.
- CRISPR screens identified caspase 8 and TRAIL receptor 1 (TRAIL-R1) as key targets.
- Inactivation of ER/Golgi pathways, UFMylation, Jagunal homolog 1 (JAGN1), or CXCR4 also overcame cFLIP requirement.
Conclusions:
- KSHV vFLIP is functionally distinct from cFLIP in PEL cells.
- PEL cell survival relies on cFLIP to suppress ligand-independent TRAIL-R1 cell death signaling.
- ER/Golgi-associated processes, UFMylation, and JAGN1 are newly implicated in cFLIP and TRAIL-R1 regulation.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response

